Clindamycin Palmitate Hydrochloride Granule, For Solution
Product Images NDC 64980-511

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Clindamycin Palmitate Hydrochloride (NDC 64980-511). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structural Formula)

Chemical structure of clindamycin palmitate hydrochloride, showing the molecular arrangement including multiple rings, side chains, and functional groups with associated hydrochloride component.*

FDA Label Image

Clindamycinlabel (Clindamycinlabel)

Label for Clindamycin Palmitate Hydrochloride for Oral Solution, USP (Pediatric) 75 mg/5 mL, 100 mL when mixed. This prescription human drug is a granule for solution taken orally, manufactured by Lyne Laboratories, Inc. and labeled by Rising Pharma Holdings, Inc. The label includes storage and preparation instructions, a barcode, and dosage information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.